Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an ...
While several effective treatment options for AFib exist, current evidence strongly suggests that pulsed field ablation (PFA) ...
Steven Mickelsen, the electrophysiologist who founded Farapulse before it was sold to Boston Scientific in 2021, is taking pulsed field ablation into new territory with the development of a device ...
13h
Medical Device Network on MSNAbbott accelerates PFA market competition in Europe with early Volt approvalThough late to the party compared to other industry leaders, Abbott joins a pulsed field ablation market poised for ...
Boston Scientific Corp. emerged as the biggest winner by far. In its fourth quarter earnings call on Wednesday, the company quantified just how successful its Farapulse PFA system has been.
14h
Zacks Investment Research on MSNInternational Expansion, Product Launches Support BSX StockBoston Scientific BSX has been gaining from product launches and accretive acquisitions. International expansion remains a ...
The company’s Farapulse PFA system was an immediate success after launching in early 2024, ultimately bringing triple-digit growth year over year to Boston Scientific’s electrophysiology ...
Applications are now being accepted for Future Docs, a leadership program of the Chattanooga-Hamilton County Medical Society ...
Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.
Boston Scientific said its fourth-quarter net income rose 12% amid robust demand for its stents, catheters and other cardiology devices. The Marlborough, Mass., medical-device maker posted fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results